Veralox Therapeutics logo
Healthcare & Life Sciences

Veralox Therapeutics

Frederick, United Statesveralox.com/

Veralox Therapeutics is a Healthcare & Life Sciences startup based in Frederick, the United States, most recent round Series A, 1 tracked investor.

Activeseries-a
series-a
Stage
2019
Founded
1
Investors

About Veralox Therapeutics

Veralox Therapeutics is a company founded in 2019 headquartered in Frederick, the United States. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

Developer of VLX-1005, a first-in-class small-molecule 12-LOX inhibitor for heparin-induced thrombocytopenia. Based in Frederick, Maryland, it is advancing the candidate toward Phase 2.

Explore Veralox Therapeutics's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in United States